Search results for "Acute coronary syndrome"

Ticagrelor monotherapy associated with less bleeding risk than dual antiplatelet therapy

In patients with acute coronary syndrome who received drug-eluting stents, ischemic outcomes did not differ with continued dual antiplatelet therapy versus de-escalation after a few weeks and up to three months to ticagrelor monotherapy, while bleeding risk was lower with the latter, according to a meta-analysis.
https://immattersacp.org/weekly/archives/2025/02/18/1.htm
18 Feb 2025